ANI Pharmaceuticals, Inc.
NGM: ANIPLive Quote
📈 ZcoreAI Score
Our AI model analyzes ANI Pharmaceuticals, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get ANIP Z-Score →About ANI Pharmaceuticals, Inc.
Healthcare
Drug Manufacturers - Specialty & Generic
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
📊 Fundamental Analysis
ANI Pharmaceuticals, Inc. demonstrates a profit margin of 8.9%, which is below the sector average, suggesting competitive pressure.
The company recently reported 29.6% revenue growth, which is well above average for the Healthcare sector.
Return on Equity (ROE) is 16.2%, which suggests room for improvement in capital utilization.
At a current price of $78.36, ANIP currently sits at the 51st percentile of its 52-week range (Range: $56.71 - $99.50).
💰 Valuation Insight
ANIP is valued broadly in line with the sector at a PE of 23.60. Analysts expect earnings growth, as indicated by a lower forward PE.
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
✅
Revenue Growth
Excellent
🔴
Return on Equity
Weak
✅
Beta (Risk)
Low Volatility
Key Financials
Market Cap
$1.78B
Trailing P/E
23.60
Forward P/E
7.45
Beta (5Y)
0.43
52W High
$99.50
52W Low
$56.71
Avg Volume
399K
Day High
Day Low